Orders growth of 22% on a reported basis, 20% organically, from strong underlying demand across segments Revenue growth 4% on a reported basis, 2% organically Net income as a percentage of revenue of 9.0%, up 600 basis points; adjusted EBITDA margin of 17.9%, down 30 basis points Reported net income of $114 million or $0.63... Read more
Q3 2021 revenues of $608.9 million, up 19.1% year-over-year (yoy); organic growth of 17.8% Q3 2021 GAAP EPS of $0.57, up 63% yoy; non-GAAP EPS of $0.63, up 50% yoy Raising FY 2021 guidance significantly on strong demand for Bruker’s products and solutions BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced financial results for... Read more
Report highlights stewardship and sustainability progress and solidifies new ESG commitments WALTHAM, Mass.–(BUSINESS WIRE)–Nov. 1, 2021– PerkinElmer, Inc. (NYSE: PKI), a global leader innovating for a healthier world, today released its 2021 Corporate Social Responsibility (CSR) Report, which summarizes the latest achievements of its environmental, social and governance (ESG) program. The report titled, “Strengthening Our... Read more
IMPACT trial data shows clear benefit in using Roche’s CINtec PLUS Cytology test for women who are at higher risk of developing cervical cancer Every year, over 604,000 women worldwide are diagnosed with cervical cancer and approximately 342,000 die from this preventable disease, caused by Infection with high-risk human papillomavirus (HPV). As recently published in... Read more
WALTHAM, Mass., Oct. 27, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the third quarter ended October 2, 2021. Third Quarter 2021 Highlights Third quarter revenue increased 9% to $9.33 billion. Third quarter GAAP diluted earnings per share (EPS) was $4.79. Third... Read more
Chicago – October 22, 2021: At this year’s ASTRO 2021 event, GE Healthcare will showcase over 15 innovative multi-modality radiation therapy solutions, offering medical practitioners imaging tools and support they need to improve patient-centered care and advance the practice of precision medicine. “GE Healthcare aims to drive improved patient outcomes through cutting-edge multi-modality radiation therapy... Read more
WASHINGTON, Oct. 21, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the third quarter 2021. All results in this release reflect only continuing operations unless otherwise noted. For the quarter ended October 1, 2021, net earnings were $1.2 billion, or $1.54 per diluted common share which represents a 33.0% year-over-year increase... Read more
New data demonstrate ENSPRYNG’s robust and sustained longer-term efficacy in preventing relapses in people with neuromyelitis optica spectrum disorder (NMOSD) More than 70% of people treated with ENSPRYNG remained relapse-free after four years in the SAkuraStar (73%) and SAkuraSky (71%) open-label extension (OLE) studies, with a favourable safety profile ENSPRYNG is now approved in 58... Read more
Basel, 14 October 2021 Short duration infusion of Gazyvaro® (obinutuzumab) is administered with a target infusion time of 90 minutes, compared to the current standard infusion time of approximately three to four hours Results from the phase IV GAZELLE study showed no new safety signals with the shorter infusion of Gazyvaro Shorter infusions could be... Read more
Ulm, Germany October 7, 2021 This year’s Confocal Raman Imaging Symposium, held online, achieved a new level of engagement with a record number of participants from around the world. Over 500 registrants signed up to view and discuss a field of 55 posters grouped under the topics: Advanced Materials Analysis; Environmental and Geo Science; and... Read more